"Uncovering Long Covid: Blood Proteins as Potential Biomarkers"
A study analyzing blood serum from 113 patients has revealed significant findings in the fight against Long Covid, indicating dysregulated activation of the complement system, altered coagulation, and ongoing thromboinflammatory responses. These findings offer potential biomarkers for diagnosing Long Covid and open new avenues for developing effective treatments. About 20% of COVID-19 patients and 5% of all infected individuals develop Long Covid, which lacks effective treatment, making these discoveries crucial for future diagnostic and therapeutic research.